GeoPolitics Pulse

The Heartbeat of World events

Ultragenyx’s Evkeeza Makes Breakthrough: First EU Treatment for Infant HoFH Patients

by ·

European Commission (EC) Extends the Approval of Evkeeza® (evinacumab) to Children as Young as 6-months Old with Homozygous Familial …Read More

Related posts:

  1. European Commission (EC) Extends the Approval of Evkeeza® – GlobeNewswire
  2. The Great British Infant Formula? Or Does the Made in USA Standard Apply to European Imports?
  3. Qatar Charity supports heart patients’ treatment in Yemen – ReliefWeb
  4. South Africans worry Trump’s aid freeze will cause HIV patients to default on treatment
  5. Trump’s aid freeze will cause HIV patients to miss treatment, South African NGOs warn